Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Moran

Showing results (291-300 of 303) with videos related to

Pageof 31
Sort By:
Journal of Crohn'S & Colitis|December 2, 2023
Biologic Therapy for Inflammatory Bowel Disease: Real-World Comparative Effectiveness and Impact of Drug Sequencing in 13 222 Patients within the UK IBD BioResourceChristina Kapizioni, Rofaida Desoki, Danielle Lam, et al.
Journal of Crohn'S & Colitis|May 10, 2026
Bayesian prior elicitation on the efficacy of medical therapies in perianal fistulizing Crohn's diseaseNurulamin M Noor, Haiyan Zheng, Zhi Cao, et al.
BMJ Open|November 24, 2025
Identification of novel molecular drivers, prognostic and diagnostic biomarkers for Inflammatory Bowel Disease (IBD): protocol for the Nottingham/AstraZeneca prospective IBD observational cohort studyAna Lilia Serna-Valverde, Eva Rodriguez-Suarez, Daniel J B Marks, et al.
Diagnostics (Basel, Switzerland)|November 27, 2021
Quantitative Magnetic Resonance Imaging in Perianal Crohn's Disease at 1.5 and 3.0 T: A Feasibility StudyAli Alyami, Caroline L Hoad, Christopher Tench, et al.
The British Journal of Radiology|January 24, 2025
Diffusion-weighted imaging to predict longer-term response in Crohn's disease patients commencing biological therapy: results from the MOTILITY trialMaira Hameed, Stuart A Taylor, Norin Ahmed, et al.
The Lancet. Gastroenterology & Hepatology|January 28, 2021
SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statementJames L Alexander, Gordon W Moran, Daniel R Gaya, et al.
Alimentary Pharmacology & Therapeutics|August 29, 2019
Infliximab induction regimens in steroid-refractory acute severe colitis: a multicentre retrospective cohort study with propensity score analysisShaji Sebastian, Sally Myers, Konstantinos Argyriou, et al.
Insights Into Imaging|March 19, 2025
MRI assessment of body composition for prediction of therapeutic response to biologic agents in patients with Crohn's diseaseNaomi S Sakai, Andrew A Plumb, Norin Ahmed, et al.
BMJ Open Gastroenterology|February 9, 2024
Determining the optimal treatment target in patients with ulcerative colitis: rationale, design, protocol and interim analysis for the randomised controlled VERDICT trialVipul Jairath, Guangyong Zou, Zhongya Wang, et al.
The Lancet. Gastroenterology & Hepatology|February 10, 2024
Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trialJames O Lindsay, Daniel Hind, Lizzie Swaby, et al.
Pageof 31

Showing results (291-300 of 303) with videos related to

Sort By:
Pageof 31
Journal of Crohn'S & Colitis|December 2, 2023
Biologic Therapy for Inflammatory Bowel Disease: Real-World Comparative Effectiveness and Impact of Drug Sequencing in 13 222 Patients within the UK IBD BioResourceChristina Kapizioni, Rofaida Desoki, Danielle Lam, et al.
Journal of Crohn'S & Colitis|May 10, 2026
Bayesian prior elicitation on the efficacy of medical therapies in perianal fistulizing Crohn's diseaseNurulamin M Noor, Haiyan Zheng, Zhi Cao, et al.
BMJ Open|November 24, 2025
Identification of novel molecular drivers, prognostic and diagnostic biomarkers for Inflammatory Bowel Disease (IBD): protocol for the Nottingham/AstraZeneca prospective IBD observational cohort studyAna Lilia Serna-Valverde, Eva Rodriguez-Suarez, Daniel J B Marks, et al.
Diagnostics (Basel, Switzerland)|November 27, 2021
Quantitative Magnetic Resonance Imaging in Perianal Crohn's Disease at 1.5 and 3.0 T: A Feasibility StudyAli Alyami, Caroline L Hoad, Christopher Tench, et al.
The British Journal of Radiology|January 24, 2025
Diffusion-weighted imaging to predict longer-term response in Crohn's disease patients commencing biological therapy: results from the MOTILITY trialMaira Hameed, Stuart A Taylor, Norin Ahmed, et al.
The Lancet. Gastroenterology & Hepatology|January 28, 2021
SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statementJames L Alexander, Gordon W Moran, Daniel R Gaya, et al.
Alimentary Pharmacology & Therapeutics|August 29, 2019
Infliximab induction regimens in steroid-refractory acute severe colitis: a multicentre retrospective cohort study with propensity score analysisShaji Sebastian, Sally Myers, Konstantinos Argyriou, et al.
Insights Into Imaging|March 19, 2025
MRI assessment of body composition for prediction of therapeutic response to biologic agents in patients with Crohn's diseaseNaomi S Sakai, Andrew A Plumb, Norin Ahmed, et al.
BMJ Open Gastroenterology|February 9, 2024
Determining the optimal treatment target in patients with ulcerative colitis: rationale, design, protocol and interim analysis for the randomised controlled VERDICT trialVipul Jairath, Guangyong Zou, Zhongya Wang, et al.
The Lancet. Gastroenterology & Hepatology|February 10, 2024
Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trialJames O Lindsay, Daniel Hind, Lizzie Swaby, et al.
Pageof 31